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Abstract
Background: Allergic rhinitis, allergic dermatitis, and food allergy are extremely common diseases, especially among
children, and are frequently associated to each other and to asthma. Smoking is a potential risk factor for these conditions,
but so far, results from individual studies have been conflicting. The objective of this study was to examine the evidence for
an association between active smoking (AS) or passive exposure to secondhand smoke and allergic conditions.
Methods and Findings: We retrieved studies published in any language up to June 30th, 2013 by systematically searching
Medline, Embase, the five regional bibliographic databases of the World Health Organization, and ISI-Proceedings
databases, by manually examining the references of the original articles and reviews retrieved, and by establishing personal
contact with clinical researchers. We included cohort, case-control, and cross-sectional studies reporting odds ratio (OR) or
relative risk (RR) estimates and confidence intervals of smoking and allergic conditions, first among the general population
and then among children. We retrieved 97 studies on allergic rhinitis, 91 on allergic dermatitis, and eight on food allergy
published in 139 different articles. When all studies were analyzed together (showing random effects model results and
pooled ORs expressed as RR), allergic rhinitis was not associated with active smoking (pooled RR, 1.02 [95% CI 0.92–1.15]),
but was associated with passive smoking (pooled RR 1.10 [95% CI 1.06–1.15]). Allergic dermatitis was associated with both
active (pooled RR, 1.21 [95% CI 1.14–1.29]) and passive smoking (pooled RR, 1.07 [95% CI 1.03–1.12]). In children and
adolescent, allergic rhinitis was associated with active (pooled RR, 1.40 (95% CI 1.24–1.59) and passive smoking (pooled RR,
1.09 [95% CI 1.04–1.14]). Allergic dermatitis was associated with active (pooled RR, 1.36 [95% CI 1.17–1.46]) and passive
smoking (pooled RR, 1.06 [95% CI 1.01–1.11]). Food allergy was associated with SHS (1.43 [1.12–1.83]) when cohort studies
only were examined, but not when all studies were combined. The findings are limited by the potential for confounding
and bias given that most of the individual studies used a cross-sectional design. Furthermore, the studies showed a high
degree of heterogeneity and the exposure and outcome measures were assessed by self-report, which may increase the
potential for misclassification.
Conclusions: We observed very modest associations between smoking and some allergic diseases among adults. Among
children and adolescents, both active and passive exposure to SHS were associated with a modest increased risk for allergic
diseases, and passive smoking was associated with an increased risk for food allergy. Additional studies with detailed
measurement of exposure and better case definition are needed to further explore the role of smoking in allergic diseases.
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Introduction
Allergic rhinitis, allergic dermatitis, and food allergy, in addition
to asthma, are extremely common diseases worldwide. Indeed,
allergic rhinitis affects 10% to 20% of the general population in
Europe and the US [1,2] and up to 40% of children [3]. The
prevalence of allergy to any food varies between 3% and 35%
[4], while that of allergic dermatitis reaches 20% in many countries
[5]. These diseases have profound consequences on the patient’s
quality of life and imply a high cost both to the patient and
insurance providers [6,7]. Among infants, these costs reach more
than US$4,000 per year per case of food allergy [8].
Recent studies have suggested that these diseases are but one
unique set of immunoglobulin-E (IgE)-mediated allergic conditions,
linked by the common thread of ‘‘atopic march’’ [9]. This concept
postulates that those conditions are a continuous state that starts
with dermatitis and food allergy and eventually progresses to asthma
and allergic rhinitis. Indeed, these diseases often co-exist in the same
patient and can predict the occurrence of each other [10].
Worldwide, the prevalence of allergic diseases has increased
substantially in the last few decades [11,12], which may have two
explanations. On the one hand, increased clinician awareness, as
well as patient and parental awareness, may have led to improved
identification and increased case presentation to physicians [12].
On the other hand, it is possible that this increase is due to
changing exposure to known and unknown risk factors [13], and
among these factors, smoking may play a role. An increased risk
of allergic diseases among individuals exposed to tobacco smoke
is biologically plausible as smoking is known to facilitate
sensitization to perennial indoor allergens, such as those caused
by furry animals, as well as to some outdoor allergens such as
pollen [14].
Increased risk of food allergy among infants exposed to tobacco
smoke is also plausible. Food allergens are likely to be found in
house dust. Swallowed foods are also inhaled or aspirated by
infants, and thus, may cause sensitization that could be facilitated
by exposure to tobacco smoke. The early and simultaneous
exposure to tobacco smoke and food allergens may interfere with
Figure 1. Flow diagram for study selection.
doi:10.1371/journal.pmed.1001611.g001
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the normal development of immunologic tolerance and thus,
facilitate sensitization to food [14].
Furthermore, smoking augments nasal responses to allergen in
atopic subjects and increases IgE, immunoglobulin G4 (IgG4), and
postallergen histamine levels in nasal lavage fluid [15,16].
Allergic conditions are, in general, more prevalent in children.
A potential effect of smoking would have a considerable impact on
public health due to the frequency of exposure worldwide. Indeed,
children and adolescents are exposed to secondhand smoke in a
proportion that varies between 27.6% in Africa and 77.8% in
Figure 2. Study-specific and random effects pooled relative risks of active smoking and allergic rhinitis.
doi:10.1371/journal.pmed.1001611.g002
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Figure 3. Study-specific and random effects pooled relative risks of passive smoking and allergic rhinitis.
doi:10.1371/journal.pmed.1001611.g003
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Table 2. Relative risks and 95% confidence intervals of allergic rhinitis by smoking exposure in cross-sectional studies.
Source Country Population Active Smoking Passive Smoking Study Size
Variables of Adjustment,
Matching, or Restriction
Bakke 1990 [53] Norway Adolescents and adults 0.68 (0.58–0.80) — 4,270 Age, sex, occupational
exposure, residence
Leuenberger 1994 [54] Switzerland Adults — 1.02 (0.82–1.28) 3,494 Not specified
Ng 1994 [55] Singapore Adults 1.16 (0.82–1.65) — 2,868 Age, race, housing,
cockroaches, occupation,
fumes
Moyes 1995 [56] New Zealand Schoolchildren — 0.80 (0.55–1.15) 5,360 Age
Wutrich 1996 [57] Switzerland Adults 0.62 (0.53–0.71) — 8,344 Age, sex, location
Min 1997 [58] Korea Children and adults 0.81 (0.38–1.34) — 8,853 Age
Siracusa 1997 [59] Italy Children and adults 0.9 (0.5–1.9) — 824 Age, sex, allergens
Austin 1997 [60] UK Children — 0.63 (0.51–0.77) 1,537 Age
Farooqi 1998 [61] UK Children — 1.04 (0.82–1.32) 1,934 Not specified
Lam 1998 [62] Hong Kong Schoolchildren 0.97 (0.86–1.09) 0.98 (0.86–1.12) 6,304 Age, sex, residence, housing
Ponsonby 1998 [63] Australia Children — 0.95 (0.86–1.05) 6,378 Age
Montefort 1998 [64] Malta Schoolchildren 1.67 (1.43–1.95) 1.13 (1.0–1.28) 4,184 Age, sex, road, pets,
parental atopy, blankets
Duhme 1998 [65] Germany Schoolchildren 1.37 (1.17–1.59) 1.01 (0.90–1.13) 13,123 Age, sex
Burr 1999 [66] UK Schoolchildren 1.30 (1.23–1.36) 1.04 (1.00–1.09) 25,393 Age, sex, location,
residence, pets, cooking and
heating fuel, housing
Dotterud 1999 [67] Russia Adults 0.69 (0.40–1.17) — 3,368 Not specified
Keles 1999 [68] Turkey Adolescents 0.6 (0.2–1.6) 0.8 (0.4–1.3) 386 Age, sex, heating, location
Plaschke 2000 [69] Sweden Adults 0.82 (0.49–1.37) — 1,370 Age, sex, location, pets,
allergens
Zacharasiewicz 2000 [70] Austria Children — 1.04 (0.93–1.17) 18,606 Age, sex, family history of
hay fever, education
Upton 2000 [71] UK Adults 0.70 (0.54–0.91) — 2,832 Age
Ozdemir 2000 [72] Turkey University freshmen 1.28 (0.82–1.98) — 1,515 Age
Hjern 2001 [73] Sweden Children — 0.96 (0.83–1.12) 4,472 Age, sex, siblings, parental
education, residence, single
parent household, country
of birth of parents, location
Hjern 2001 [73] Sweden Adults 0.78 (0.72–0.84) — 6,909 Age, sex, education,
residence, country of birth,
location
Janson 2001 [74] World Adults — 1.02 (0.81–1.20) 7,882 Age, sex, allergens, IgE,
location
Simpson 2001 [75] UK Adults 0.78 (0.65–0.93) — 5,687 Sex, allergens, pets
Dotterud 2001 [76] Russia Schoolchildren —– 0.90 (0.69–1.17) 1,684 Age, sex, carpets, dampness,
pets, heating type
Kalyoncu 2001 [77] Turkey University students 1.24 (1.01–1.53) 1.20 (1.06–1.35) 4,639 Age, sex, region, family
atopy, pets, elder siblings
Lee 2001 [78] Korea Schoolchildren — 1.19 (1.11–1.28) 38,955 Age, sex, region, body mass
index, carpets, pets, location
Stazi 2002 [79] Italy Children — 2.2 (1.2–4.1) 201 Age, sex
Peroni 2003 [80] Italy Preschool children — 1.19 (0.89–1.59) 1,402 Age
Barraza 2003 [81] Mexico Schoolchildren — 1.37 (1.23–1.52) 6,174 Age, school, cockroaches,
respiratory problems, use of
carpets, humidity, family
history of asthma
Monteil 2004 [82] Trinidad &
Tobago
Schoolchildren — 1.41 (1.26–1.59) 3,170 Age
Lee 2004 [83] Hong Kong School children — 0.81 (0.72–0.91) 4,448 Age, sex, birth weight,
siblings, respiratory tract
infections, parental atopy,
pets, study period
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Table 2. Cont.
Source Country Population Active Smoking Passive Smoking Study Size
Variables of Adjustment,
Matching, or Restriction
Kramer 2004 [84] Germany School beginners — 0.86 (0.38–1.96) 1,220 Age, sex, atopy, nationality
Demir 2004 [85] Turkey Schoolchildren — 2.43 (1.32–4.52) 1,064 Age
Miyake 2004 [86] Japan Schoolchildren — 1.11 (0.98–1.27) 5,539 Age, sex, grade, older
siblings, maternal age at
child birth, pets, history of
other allergic diseases
Annesi-Maesano 2004 [87] France Adolescents 1.65 (1.48–1.84) 1.15 (1.09–1.22) 14,578 Age, sex
De 2005 [88] Ireland Children — 1.16 (0.43–3.12) 81 Not specified
Topp 2005 [89] Germany Adults — 1.10 (0.93–1.30) 4,093 Age, sex, social class,
location
Maziak 2005 [90] Syria Adults — 1.12 (0.85–1.48) 1,118 Age, sex, familial atopy,
socioeconomic status,
occupational
Miyake 2005 [91] Japan Pregnant women 1.10 (0.85–1.42) 1.33 (1.09–1.62) 1,002 Age, sex, familial atopy,
pets, gestation, parity,
family income, education,
mite antigen level
Bugiani 2005 [92] Italy Young adults 0.76 (0.69–0.84) — 17,666 Not specified
Obihara 2005 [93]a South Africa Children — — 861 Age, sex, maternal atopy,
breast feeding, siblings,
household income,
tuberculin test
Strumylaite 2005 [94] Lithuania Children — 0.85 (0.20–3.45) 594 Age
Lund 2006 [95]b France Mature women 1.10 (0.92–1.30) 1.31 (1.0–1.6) 2,197 Age, sex
Kurosaka 2006 [96] Japan Schoolchildren — 0.82 (0.78–0.87) 35,213 Age, sex, pets
Sakar 2006 [97] Turkey Adults 1.30 (0.99–1.71) 1.33 (0.96–1.83) 1,336 Age, sex, family atopy
Ho 2007 [98] Hong Kong Adults — 1.34 (0.93–1.94) 200 Age, sex, education,
occupational exposures
Horak 2007 [99] Austria Preschool children — 1.31 (0.90–1.90) 1,737 Age, sex, familial atopy,
education, family size, pets,
breastfeeding, healthy
nutrition
Ebbert 2007 [100] USA Adults — 1.16 (0.85–1.59) 1,007 Not specified
Tanaka 2007 [101] Japan Children — 1.07 (0.98–1.16) 23,044 Age, sex, location, familial
atopy, siblings, education
level
Zuraimi 2008 [102] Singapore Preschool children — 1.22 (1.11–1.35) 4,759 Age, sex, familial atopy,
race, socioeconomic status,
housing type,
breastfeeding, food allergy,
respiratory infections,
housing conditions, traffic
density
Foliaki 2008 [103] Pacific countries Children — 1.05 (0.99–1.12) 17,683 Age, sex, country
Gomez 2008 [104] Argentina Adolescents 1.72 (1.48–1.99) — 3,000 Age
Kabir 2009 [105] Ireland Children 1.30 (1.01–1.67) 2,809 Age, sex
Brescianini 2009 [106] Italy Schoolchildren — 1.17 (0.79–1.76) 481 Age, sex, family atopy, body
mass index, pets, physical
activity, diet, location
Musharrafieh 2009 [107] Lebanon Adolescents — 1.0 (0.8–1.2) 3,115 Age, sex, nationality,
regions, school type, traffic
Gonzalez-Diaz 2010 [108] Mexico Children and Adolescents — 1.37 (1.23–1.53) 23,191 Age
Bedolla-Barajas 2010 [109] Mexico Schoolchildren — 1.01 (0.48–2.13) 740 Age
Wang 2010 [110] Canada Schoolchildren — 1.00 (0.81–1.24) 8,334 Age, sex, body mass index,
location, birthplace,
ethnicity, maternal
education, siblings, fuel use,
pets, acetaminophen,
physical activity
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Europe [17] and approximately 14% of all children were exposed
to maternal smoking during pregnancy [18].
Several studies have assessed the association between smoking
exposure and allergic diseases. In each of the allergic conditions,
results were conflicting and alternated between the harmful effects
of smoking [14,19,20] and protection [21–23], while some studies
could not find evidence of any effect [24–26].
Except for a systematic review and meta-analysis examining the
relationship between smoking and asthma in children [27], to our
knowledge, there is no comprehensive meta-analysis that examines
the evidence for a relationship between smoking and allergic
conditions. We, therefore, summarized the scientific evidence and
carried out a meta-analysis on exposure to active and passive
smoking and the risk of allergic rhinitis, allergic dermatitis, and
food allergy among adults and children/adolescents.
Methods
Data Sources and Searches
We searched databases from 1966 to June 30th, 2013, to identify
all potentially eligible studies. For Medline, we applied the following
algorithm both in medical subject heading and in free text words:
(‘‘SEASONAL ALLERGIC RHINITIS’’ OR ‘‘POLLEN AL-
LERG*’’ OR ‘‘POLLINOSIS’’ OR ‘‘POLLINOSES’’ OR ‘‘HAY
FEVER’’ OR ‘‘RHINITIS, ALLERGIC, NONSEASONAL’’ OR
‘‘RHINITIS, ALLERGIC, PERENNIAL’’ OR ‘‘DERMATITIS,
ATOPIC’’ OR ECZEMA OR ‘‘FOOD ALLERGIES’’ OR
‘‘HYPERSENSITIVITY, FOOD’’) AND (SMOKING OR TO-
BACCO OR CIGARETT*). We used similar strategies to search
Embase and the five regional bibliographic databases of the World
Health Organization (AIM, LILACS, IMEMR, IMSEAR,
WPRIM). We searched meeting abstracts using the ISI Proceedings
database from its inception in 1990 to 2013. We also examined the
references of every article retrieved and those of recent reviews of
allergic rhinitis and smoking [16,28–33] and established personal
contact with clinical researchers to trace further publications or
reports. We considered including any relevant article, indepen-
dently of the language of publication.
Study Selection
Studies were included if: (1) they presented original data from
cohort, case-control, or cross-sectional studies (ecologic studies
were not included); (2) the outcome of interest was clearly defined
as allergic rhinitis, allergic dermatitis, or food allergy; (3) one of the
exposure factors was smoking, either by the subjects themselves or
their relatives; (4) they provided estimates of odds ratio (OR),
relative risk (RR), or prevalence odds ratio and their confidence
intervals, or enough data to calculate them. If data on the same
population were duplicated in more than one study, the most
recent study was included in the analysis. When data for different
types or levels of exposure were available in the same study, such
as passive smoking, active smoking, or maternal smoking during
pregnancy, we considered each type of exposure separately. We
developed a standard data-recording form in which we recorded
authors, year of publication, study location, sample size, outcome,
outcome measurement details, effect estimator (OR, RR, other),
effect estimate, 95% CIs, adjustment factors used, and study
design including if the International Study of Asthma and Allergies
in Childhood (ISAAC) methodology was followed. ISAAC is a
large international epidemiologic study on risk factors of allergic
diseases, the methods of which are widely used. When further
clarification was necessary, we attempted to contact the authors.
Abstracts were reviewed independently by two authors (BT
and JS).
Table 2. Cont.
Source Country Population Active Smoking Passive Smoking Study Size
Variables of Adjustment,
Matching, or Restriction
Vlaski 2011 [111] Macedonia Adolescents — 0.99 (0.88–1.11) 3,026 Age, sex, diet, type of
cooking and heating, pets,
maternal education, siblings
Virkkula 2011 [112] Finland Children — 2.29 (1.07–4.87) 38 Age
Hakansson 2011 [113] Denmark Adults 0.79 (0.68–0.92) — 3,471 Age, sex
Chen 2012 [114] Taiwan Children — — 4,221 Age, sex, parental atopy,
parental education
Pen˜aranda 2012 [115] Colombia Children — 1.19 (0.99–1.42) 3,256 Age, asthma, dermatitis, use
of acetaminophen and
antibiotics, maternal
education, caesarean
delivery
Pen˜aranda 2012 [115] Colombia Adolescents 1.4 (1.2–1.7) — 3,829 Age, asthma, dermatitis, use
of acetaminophen,
consumption of fast-food,
cats
Tanaka 2012 [116] Japan Pregnant women 1.01 (0.84–1.23) 1.50 (1.14–1.96) 1,743 Age, sex, region of
residence, parental atopy,
household income,
education
Montefort 2012 [117] Malta Children 1.40 (1.11–1.76) 1.11 (1.02–1.20) 7,955 Age
Mitchell 2012 [118] Multiple countriesChildren — 1.10 (1.08–1.12) 573,061 Age, sex, language, region,
gross national income
aOnly data on maternal smoking during pregnancy are available.
bThis study used cases of rhinitis at large, not only allergic rhinitis.
doi:10.1371/journal.pmed.1001611.t002
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Quality Assessment
Study quality was assessed using a five-point binary scale
specifically developed for this study. The scale is based on the
Newcastle-Ottawa scale [34] with modifications in view of
standard guidelines and our own judgment. The Newcastle-
Ottawa scale is a scoring system that assesses every aspect of an
observational epidemiologic study from a methodological point of
view. For this meta-analysis, we tried to use those elements that
were common to all epidemiologic designs and thus shortened the
scale considerably. We used the following criteria labelled as ‘‘yes’’
or ‘‘no’’: (1) whether assessment of the smoking habit included
duration and/or quantity (yes) or not (no); (2) whether rhinitis
diagnosis included clinical features and IgE or skin prick test (SPT)
measurements (yes) or was based on clinical examination or
questionnaire only (no), whether dermatitis diagnosis included
clinically assessed diagnosis (yes) or was based on questionnaire
information only (no), whether the diagnosis of food allergy was
based on clinical diagnosis with SPT, IgE, or open-challenge test
(yes) or was based on questionnaire information only (no); (3)
whether results were adjusted for age, sex, and at least one other
potential confounder (yes) or not (no); (4) whether participation
exceeded 80% of the people initially approached (yes) or not (no);
and, finally (5) whether the target population was clearly defined
(yes) or, on the contrary, based on convenience sampling of
subjects such as patients of a single consultation (no). Throughout
this assessment, when the information on a specific item was not
provided by the authors, we graded this item as ‘‘no.’’ We carried
out a pooled analysis on those studies that fulfilled at least three
criteria and compared with those that scored fewer than three. As
a secondary analysis, we stratified our results on criterion 1 and
present the pooled relative risks in Table S2.
Data extraction and quality scoring were performed indepen-
dently by two reviewers (BT and JS) and the results were merged
by consensus. The complete protocol and results for quality
scoring are available in Table S1.
Data Synthesis and Analysis
We weighted the study-specific log odds ratios for case control
and cross-sectional studies, and log relative risks for cohort studies
by the inverse of their variance to compute a pooled relative risk
Table 3. Pooled relative risks and 95% confidence intervals of allergic rhinitis and smoking.
Study Type Number of Studies
RR (95% CI) Fixed
Effects
RR (95% CI) Random
Effects Ria (95% CI) Q test (p-Value)
Active smoking
All studies 34 1.06 (1.03–1.08) 1.02 (0.92–1.15) 0.95 (0.90–0.99) 0.00001
Cohort studies 4 0.87 (0.82–0.93) 0.91 (0.77–1.07) 0.82 (0.47–1.00) 0.0024
Case-control studies 3 1.19 (0.99–1.45) 0.97 (0.55–1.70) 0.88 (0.59–1.00) 0.0009
Cross-sectional studies 27 1.09 (1.06–1.12) 1.03 (0.91–1.18) 0.95 (0.91–1.00) 0.00001
Cohort+case-control studies 7 0.90 (0.85–0.96) 0.98 (0.81–1.18) 0.87 (0.66–1.00) 0.00001
Full adjustment 18 1.07 (1.04–1.10) 1.02 (0.88–1.20) 0.96 (0.92–1.00) 0.00001
Incomplete adjustment 16 1.03 (0.98–1.08) 1.02 (0.86–1.22) 0.91 (0.83–0.99) 0.00001
Adults only 21 0.84 (0. 81–0.87) 0.90 (0.82–0.99) 0.82 (0.66–0.97) 0.00001
Children/adolescents only 10 1.35 (1.30–1.39) 1.40 (1.24–1.59) 0.90 (0.77–1.00) 0.00001
Children ISAAC method 8 1.39 (1.34–1.44) 1.50 (1.35–1.66) 0.85 (0.63–1.00) 0.00001
Children non-ISAAC method 2 0.96 (0.86–1.08) 0.96 (0.86–1.08) 0.00 (0.00–1.00) 0.34
Quality score $3 15 0.89 (0.86–0.93) 0.95 (0.85–1.06) 0.86 (0.73–0.99) 0.00001
Quality score ,3 19 1.19 (1.16–1.23) 1.09 (0.92–1.29) 0.96 (0.91–1.00) 0.00001
Passive Smoking
All studies 63 1.08 (1.07–1.10) 1.10 (1.06–1.15) 0.87 (0.75–0.99) 0.00001
Cohort studies 9 1.08 (1.03–1.13) 1.14 (0.96–1.34) 0.90 (0.76–1.00) 0.00001
Case-control studies 3 1.13 (0.91–1.39) 1.14 (0.46–2.82) 0.95 (0.84–1.00) 0.00001
Cross-sectional studies 51 1.08 (1.07–1.10) 1.09 (1.05–1.14) 0.86 (0.72–0.99) 0.00001
Cohort+case-control studies 12 1.08 (1.03–1.13) 1.13 (0.96–1.34) 0.91 (0.79–1.00) 0.00001
Full adjustment 37 1.07 (1.06–1.09) 1.07 (1.03–1.12) 0.86 (0.72–1.00) 0.00001
Incomplete adjustment 26 1.17 (1.13–1.20) 1.15 (1.04–1.27) 0.86 (0.74–0.97) 0.00001
Adults only 13 1.17 (1.10–1.24) 1.17 (1.03–1.32) 0.74 (0.50–0.98) 0.00001
Children/adolescents only 50 1.08 (1.07–1.09) 1.09 (1.04–1.14) 0.89 (0.77–0.99) 0.00001
Children ISAAC method 28 1.10 (1.09–1.12) 1.11 (1.07–1.16) 0.84 (0.66–1.00) 0.00001
Children non-ISAAC method 21 0.98 (0.95–1.01) 1.06 (0.95–1.19) 0.89 (0.78–1.00) 0.00001
Maternal pregnancy smoking 11 1.01 (0.96–1.06) 1.07 (0.92–1.28) 0.83 (0.60–1.00) 0.00001
Quality score $3 30 1.09 (1.08–1.11) 1.10 (1.04–1.15) 0.86 (0.71–1.00) 0.00001
Quality score ,3 33 1.07 (1.04–1.09) 1.10 (1.02–1.19) 0.88 (0.78–0.98) 0.00001
aProportion of total variance due to between-study variance.
doi:10.1371/journal.pmed.1001611.t003
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and its 95% confidence interval. For each study, we used the
estimate of the effect measure that was adjusted for the largest
number of confounders. We present both fixed-effects and random
effects pooled estimates but use the latter when heterogeneity was
present. Odds ratios from case-control studies were assumed to be
unbiased estimates of the relative risk [35].
We used a version adapted to small samples of the DerSimonian
and Laird Q test to check for heterogeneity [36]. The null
hypothesis of this test is the absence of heterogeneity. To quantify
this heterogeneity we calculated the proportion of the total variance
due to between-study variance (Ri statistic) [36]. Furthermore, we
explored the origin of heterogeneity by restricting the analysis to
subgroups of studies defined by study characteristics such as study
design, type of exposure (active or passive smoking), and age of the
participants (children/adolescents or adults).
To check whether the pooled estimates were significantly
different between subgroups we carried out a meta-regression with
the global effect as dependent variable and the subgroup variable
as moderator.
We assessed publication bias, first visually, using funnel plots
and then, more formally, using the test proposed by Egger and
colleagues [37]. We also used the trim-and-fill method to correct
for potential publication bias. All analyses were performed with
the software HEpiMA version 2.1.3 [38] and STATA version 12
with its macros metabias, metareg, and metatrim.
The secondary analyses (children and adolescents/
adults, ISAAC/other, cohort and case-control studies combined/
cross-sectional studies, high quality/low quality) were planned a
priori.
Results
We identified 196 studies, published in 139 different articles and
carried out in 51 countries, on active or passive smoking and
allergic diseases that met our inclusion criteria (Figure 1). The data
from one study were obtained from the authors [39]. We found 97
studies on allergic rhinitis [19,21,24,39–118], 91 on allergic
dermatitis [19,20,22,24–26,44–46,48,53,60–65,67,73,75,76,78,
83–87,91,93,96,97,99,101–103,105–107,110,111,116–165], and
eight on food allergies [14,23,26,73,126,136,166–168].
A large majority of the articles retrieved initially were excluded
either because they did not provide any effect measure or the
outcome was allergy at large. More specifically, of the studies that
could have been relevant to our meta-analysis but were finally
excluded, eight were discarded because they were an early version
of cohort studies updated in subsequent publications [169–176].
Other studies published their results several times [175–181] in
which case we chose to include the most complete report. Some
studies were excluded because the outcome was not allergic rhinitis,
dermatitis, or food allergy but rather SPT or IgE concentrations
Figure 4. Funnel plot of relative risk versus standard error of relative risk: allergic rhinitis, active smoking.
doi:10.1371/journal.pmed.1001611.g004
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[182–192]. We also excluded nine studies that used either
unspecific outcomes such as nasal symptoms [193,194], or a
mixture of allergic diseases as a single outcome [195–201]. Eight
studies [138,202–208] were excluded as they did not present any
effect measure. Finally, one ecologic study was not considered
further [209].
Globally, heterogeneity was substantial overall and similarly
high after stratification by design, quality features (including
adjustment for confounders), and study population. Given the
substantial heterogeneity, we focused on the random effects
analyses; however, the fixed effects analyses are presented for
comparison and only discussed where they differ.
Allergic Rhinitis
Thirty-four studies on active smoking and 63 studies on passive
smoking were available (Figures 2 and 3; Tables 1 and 2). The
overwhelming majority of the studies assessed diagnosis through
questionnaire and only seven studies used SPT or IgE measure-
ments for the case definition [39,42,46,52,57,101,113]. The study
by Wright and colleagues [42] measured SPT reactivity but used a
definition of physician diagnosed allergic rhinitis that included
both SPT-positive and SPT-negative children. More than half of
the studies used ISAAC criteria for the definition of allergic
rhinitis. Finally, 11 studies assessed maternal smoking during
pregnancy [44,45,47–49,60,70,81,93,99,114].
Table 3 shows the results for associations between smoking and
allergic rhinitis.
Active Smoking
Using random effects analysis, there was no significant
association between active smoking and the risk of allergic rhinitis
when all studies are considered (RR = 1.02; 95% CI 0.92–1.15).
Using fixed effect analysis for all studies, there was a significant
association between active smoking and risk of rhinitis (RR = 1.06,
95% CI 1.03–1.08); however, this may be explained by the
considerable amount of heterogeneity due to differences in
designs, case, and exposure definitions and adjustment for
confounders. It is remarkable that, under the fixed effects model,
the result of the cross-sectional subgroup (RR = 1.09; 95% CI
1.06–1.12) is statistically significant and opposed to the result of
the cohort studies subgroup (RR = 0.87; 95% CI 0.82–0.93).
When restricting the analysis to the ten studies carried out on
children and adolescents, active smoking was associated with an
increased pooled relative risk of 1.40 (95% CI 1.24–1.59). In
further sub-group analyses, the association was significant in the
studies that used the standardized ISAAC protocol (RR = 1.50,
95% CI 1.35–1.66), but not those that used their own protocol
(RR = 0.96, 95% CI 0.88–1.08). A reverse association between
active smoking and allergic rhinitis was observed in adults only
(RR = 0.90, 95% CI 0.82–0.99)
Figure 5. Funnel plots of relative risk versus standard error of relative risk: allergic rhinitis, passive smoking.
doi:10.1371/journal.pmed.1001611.g005
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Passive Smoking
Using random effects analysis, there was a significant association
passive smoking and allergic rhinitis (RR = 1.10, 95% CI 1.06–
1.15). Similar findings were observed in subgroup analyses by
adjustment for confounding variables (RR = 1.07; 95% CI 1.03–
1.12 for full adjustment, RR = 1.15; 95% CI 1.04–1.27 for incomplete
adjustment), quality scores (RR = 1.10; 95% CI 1.04–1.15 for high
quality, RR = 1.10; 95% CI 1.02–1.19 for low quality), and for cross-
sectional studies (RR = 1.09; 95% CI 1.05–1.14); however, there was
no significant association between passive smoking and allergic rhinitis
when restricting the analysis to cohort studies (RR = 1.14; 95% CI
0.96–1.34) or case-control studies (RR = 1.14; 95% CI 0.46–2.82).
Figure 6. Study-specific and random effects pooled relative risks of active smoking and allergic dermatitis.
doi:10.1371/journal.pmed.1001611.g006
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In subgroup analyses based on age group, a significant
association between passive smoking and allergic rhinitis was
observed in adults only (RR = 1.17; 95% CI 1.03–1.32) and in
children and adolescents (RR = 1.09; 95% CI 1.04–1.14). For
maternal pregnancy smoking, there was no evidence for a a
significant increase in the risk of allergic rhinitis in the offspring
(RR = 1.07; 95% CI 0.92–1.28).
Publication Bias
The funnel plot of active smoking seems to be slightly skewed to
the left, which indicates a potential lack of studies that favor a
positive association of the disease with smoking (Figure 4).
However, the Egger’s test of asymmetry yielded a nonsignificant
p-value of 0.27 and no hypothetical study was suggested as
missing in the trim-and-fill procedure. The funnel plot for passive
Figure 7. Study-specific and random effects pooled relative risks of passive smoking and allergic dermatitis.
doi:10.1371/journal.pmed.1001611.g007
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Table 5. Relative risks and 95% confidence intervals of allergic dermatitis by smoking exposure in cross-sectional studies.
Source Country Population Active Smoking Passive Smoking Study Size
Variables of Adjustment,
Matching, or Restriction
Edman 1988 [137] Sweden Adults 2.37 (0.98–5.76) — 425 Not specified
Bakke 1990 [53] Norway Adolescents and adults 1.12 (1.01–1.24) — 4,270 Age, sex, occupational
exposure, residence
Volkmer 1995 [138] Australia Preschool children — 0.80 (0.71–0.91) 14,124 Natural gas for cooking,
heating and cooling sources
Austin 1997 [60] UK Children — 0.88 (0.74–1.05) 1,537 Age
Liss 1997 [139] Canada Adults 0.86 (0.61–1.22) — 1,326 Not specified
Scha¨fer 1997 [140] Germany Preschool children — — 678 Age
Duhme 1998 [65] Germany Schoolchildren 1.32 (1.07–1.62) 0.97 (0.85–1.10) 13,123 Age, sex
Lam 1998 [62] Hong Kong Schoolchildren 1.06 (0.91–1.24) 0.91 (0.80–1.03) 6,304 Age, sex, residence, housing
Montefort 1998 [64] Malta Schoolchildren 1.76 (1.47–2.12) — 4,184 Age, sex, road, pets, parental
atopy, blankets
Farooqi 1998 [61] UK Children — 0.97 (0.75–1.26)* 1,934 Not specified
Dotterud 1999 [67] Russia Adults 2.42 (1.24–4.71) — 3,368 Not specified
Dotterud 2001 [76] Russia Schoolchildren — 0.93 (0.78–1.11) 1,684 Age, sex, carpets, dampness,
pets, heating type
Hjern 2001 [73] Sweden Children — 0.88 (0.75–1.03) 4,472 Age, sex, siblings, parental
education, residence, single
parent household, country of
birth of parent, location
Lee 2001 [78] Korea Schoolchildren — 1.09 (0.99–1.20) 38,955 Age, sex, region, BMI, carpets,
pets, location
Simpson 2001 [75] UK Adults 0.9 (0.75–1.07) — 5,687 Not specified
Linneberg 2003 [141] Denmark Adolescents and adults 2.35 (1.72–3.19) — 1,112 Age, sex, ear piercing
Montnemery 2003 [142] Sweden Adults 1.03 (0.91–1.24) — 8,469 Not specified
Kramer 2004 [84] Germany School beginners — 1.97 (1.23–3.16) 1,220 Age, sex, atopy, nationality
Demir 2004 [85] Turkey Schoolchildren — 1.30 (0.46–3.83) 621 Age
Annesi-Maesano 2004 [87] France Adolescents 1.39 (1.23–1.56) 0.9 (0.9–1.3) 14,578 Age, sex
Miyake 2004 [86] Japan Schoolchildren — 1.04 (0.89–1.22) 5,539 Age, sex, grade, older siblings,
maternal age at child birth,
pets, parental allergic
diseases.
Yemaneberhan 2004 [143] Ethiopia Children and adults 1.70 (0.97–2.97) 2.13 (1.31–3.46) 12,876 Age, sex, socioeconomic
status, residence, kerosene
use
Lee 2004 [83] Hong Kong Schoolchildren — — 4,448 Age, sex, birth weight,
siblings, respiratory tract
infections, parental atopy,
pets, study period
Heudorf 2005 [144] Germany Children — 2.34 (1.04–5.28) 287 Age
Miyake 2005 [91] Japan Pregnant women 0.66 (0.43–1.02) 1.08 (0.81–1.44) 1,002 Age, sex, familial atopy, pets,
gestation, parity, family
income, education, mite
antigen level
Montnemery 2005 [145] Sweden Adults 1.35 (1.04–1.75) — 6,109 Not specified
Obihara 2005 [93] South Africa Children — — 861 Age, sex, maternal atopy,
breast feeding, siblings,
household income, tuberculin
test
Kurosaka 2006 [96] Japan Schoolchildren — 0.99 (0.93–1.05) 35,242 Age
Sakar 2006 [97] Turkey Adults 1.31 (0.97–1.78) — 1,336 Not specified
Dotterud 2007 [146] Norway Adults 1.20 (0.89–1.60) — 1,236 Age, sex, atopic dermatitis,
rhinitis and asthma
Horak 2007 [99] Austria Preschool children — 1.06 (0.76–1.48) 1,737 Age, sex, familial atopy,
education, family size, pets,
breastfeeding, nutrition
Smoking and Allergic Diseases
PLOS Medicine | www.plosmedicine.org 16 March 2014 | Volume 11 | Issue 3 | e1001611
Table 5. Cont.
Source Country Population Active Smoking Passive Smoking Study Size
Variables of Adjustment,
Matching, or Restriction
Tanaka 2007 [101] Japan Children — 1.08 (1.02–1.14) 23,044 Age, sex, location, familial
atopy, siblings, education
level
Zuraimi 2008 [102] Singapore Preschool children — 1.02 (0.95–1.09) 4,759 Age, familial atopy, race,
socioeconomic status,
housing type, breastfeeding,
food allergy, respiratory
infections, dampness
Al-Sahab 2008 [147] Lebanon Adolescents — 1.46 (1.11–1.94) 2,893 Age, sex, exercise, traffic,
asthma, rhinitis
Ergin 2008 [148] Turkey Schoolchildren — 1.30 (0.89–1.91) 1,644 Age
Foliaki 2008 [103] Pacific countries Children — 1.20 (1.11–1.30) 20,876 Age, sex and country
Sua´rez-Varela 2008 [149] Spain Schoolchildren — 1.03 (0.99–1.06) 59,040 Age, sex, asthma, rhinitis,
siblings, mother’s education
Attwa 2009 [150] Egypt Adult men 3.59 (1.0–13.5) — 163 Sex
Meding 2009 [151] Sweden Adults 1.05 (0.95–1.16) — 13,452 Age, sex, history of atopy
Brescianini 2009 [106] Italy Schoolchildren — 1.22 (0.77–1.95) 481 Age, sex, family atopy, BMI,
pets, physical activity, diet,
location
Musharrafieh 2009 [107] Lebanon Adolescents — 1.1 (0.9–1.4) 3,115 Age, sex, nationality, regions,
school type, traffic, asthma,
rhinitis
Kabir 2009 [105] Ireland Children — 1.24 (0.90–1.70) 2,809 Age, sex
Lipinska 2009 [152] Poland Children — 3.40 (1.19–11.86) 283 Not specified
Xepapadaki 2009 [153] Greece Preschool children — 0.98 (0.79–1.22) 2,374 Age, sex
Wang 2010 [110] Canada Schoolchildren — 1.05 (0.79–1.41) 8,334 Age, sex, BMI, location,
birthplace, ethnicity, maternal
education, siblings, pets,
acetaminophen, physical
activity
Ro¨hrl 2010 [154] Sweden Adolescents — 0.85 (0.59–1.23) 6,095 Age, sex, flexural eczema and
nickel allergy
Thyssen 2010 [155] Denmark Adults 1.28 (1.10–1.49) — 3,471 Age, sex, alcohol
consumption, educational
level
Meding 2010 [156] Sweden Adults 1.15 (1.08–1.22) — 25,428 Age, sex, history of atopy
Yang 2011 [157] USA Adults 0.88 (0.71–1.10) 1.21 (0.85–1.74) 2,974 Not specified
Vlaski 2011 [111] Macedonia Adolescents — 0.93 (0.80–1.09) 3,026 Age, sex, diet, source of
heating, pets, maternal
education, siblings
Civelek 2011 [158] Turkey Schoolchildren — 1.35 (1.17–1.56) 6,755 Age
Dei-Cas 2011 [159] Argentina Children — 1.45 (1.02–2.08) 722 Age
Apfelbacher 2011 [160] Germany Children and adolescents — 0.90 (0.77–1.04) 17,270 Age, sex, socioeconomic
status, migrant status,
siblings, breastfeeding,
mother’s alcohol
consumption, pets, infection,
parental atopy.
Park 2011 [161] Korea Adults 1.69 (1.27–2.24) — 1,990 Age, sex, BMI, education,
income, alcohol, fish
consumption.
Berglind 2011 [162] Sweden Adults 1.03 (1.01–1.04) — 27,793 Neck and shoulder pain,
depression, well-being, job
strain, low back pain, physical
activity at work
Breunig 2012 [163] Brazil Male adolescents 1.06 (0.75–1.50) — 2,201 Age, sex, white race,
socioeconomic level, triceps
skin fold, acne
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smoking (Figure 5) and the corresponding results of the Egger’s test
did not show any evidence of publication bias (p= 0.53), but two
new studies were imputed in the trim-and-fill procedure yielding a
modified pooled relative risk of 1.10 (95% CI 1.05–1.14).
Allergic Dermatitis
We retrieved 33 studies on active smoking and 58 studies on
passive smoking (Figures 6 and 7; Tables 4 and 5). About one-third
of the studies used ISAAC criteria for case definition. Nineteen
Table 5. Cont.
Source Country Population Active Smoking Passive Smoking Study Size
Variables of Adjustment,
Matching, or Restriction
Yi 2012 [164] Korea Children — 1.30 (1.23–1.38) 6,372 Age, sex, residence, income,
parental education, atopy, IgE
level, rhinitis
Ro¨nmark 2012 [165] Sweden Adults 1.20 (1.16–1.25) — 18,087 Age, sex, family history of
atopy, exposure to gas, dust
or fumes at work
Tanaka 2012 [116] Japan Pregnant women 1.08 (0.85–1.37) 1.42 (0.99–2.05) 1,743 Age, sex, region of residence;
parental atopy, income,
education
Montefort 2012 [117] Malta Children 1.68 (1.35–2.09) 1.24 (1.13–1.37) 7,955 Age
Mitchell 2012 [118] Worldwide Children — 1.11 (1.09–1.14) 573,061 Age, sex, language, region,
gross national income
doi:10.1371/journal.pmed.1001611.t005
Figure 8. Funnel plots of relative risk versus standard error of relative risk: allergic dermatitis, active smoking.
doi:10.1371/journal.pmed.1001611.g008
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studies assessed maternal smoking during pregnancy [44,45,48,
83,93,99,121,127,128,130,133–136,140,153,158,160,164].
Active Smoking
Using random effects analysis, active smoking was significantly
associated with an increased risk of allergic dermatitis overall
(RR = 1.21; 95% CI 1.14–1.29) and in both adults (RR = 1.14;
95% CI 1.07–1.22) and in children and adolescents (RR = 1.36;
95% CI 1.17–1.46)
In sub-group analyses, the association between active smoking
and allergic dermatitis was similar based on age, adjustment for
confounding, quality scores, and for cohort studies and cross-
sectional studies, although there was no significant association
between active smoking and allergic dermatitis observed in the
four case-control studies (RR = 1.47; 95% CI 0.92–2.32).
Passive Smoking
Using random effects analysis, passive smoking was associated
with an increased risk of allergic dermatitis in the general
population (RR = 1.07; 95% CI 1.03–1.12).
In sub-group analyses, the association between passive smoking
and allergic dermatitis was significant when restricted to cross-
sectional studies (RR = 1.07; 95% CI 1.02–1.12), but not for
cohort (RR = 1.09; 95% CI 0.96–1.23) or case-control studies
(RR = 1.10; 95% CI 0.88–1.38). A significant association between
passive smoking and allergic dermatitis was observed for those
studies with adjustment for confounding variables (RR = 1.08;
95% CI 1.03–1.13) and higher quality scores (RR = 1.11; 95%
CI 1.05–1.18), but not those without adjustment (RR = 1.06; 95%
CI 0.98–1.14) or low quality scores (RR = 1.03; 95% CI
0.96–1.11).
A significant association was observed in those studies
including adults only (RR = 1.26; 95% CI 1.02–1.55) and in
those including children and adolescents only (RR = 1.06; 95% CI
1.01–1.11). No significant association was observed between
maternal smoking and allergic dermatitis (RR = 1.07; 95% CI
0.96–1.19).
Publication Bias
The Egger’s test for asymmetry of the funnel plot of active
smoking (Figure 8) yielded a p-value of 0.28 and no study was
added in the trim-and-fill procedure. No asymmetry was detected
for passive smoking (Figure 9) through the Egger’s test (p= 0.33)
but the trim-and-fill procedure suggested that ten potential studies
were missing. The modified random effects pooled relative risk was
1.04 (95% CI 1.00–1.08).
Food Allergies
We retrieved only one study for active smoking and six studies
for passive smoking, while three studies assessed maternal smoking
Figure 9. Funnel plot of relative risk versus standard error of relative risk: allergic dermatitis, passive smoking.
doi:10.1371/journal.pmed.1001611.g009
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during pregnancy (Figure 10; Table 7). All were carried out in
children or infants populations.
Active Smoking
The only available study on active smoking and food allergies did
not show any significant association (RR = 0.58; 95% CI 0.21–1.55).
Passive Smoking
Using random effect analysis, including the six studies
investigating exposure to secondhand smoke, showed that passive
smoking was associated with a nonsignificant increase of the risk of
food allergy (RR = 1.16; 95% CI 0.85–1.59). When the only cross-
sectional study was excluded and the analysis was based on five
Figure 10. Study-specific and random effects pooled relative risks of passive smoking and food allergies.
doi:10.1371/journal.pmed.1001611.g010
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cohort studies, passive smoking was significantly associated with an
increased risk of food allergy (RR = 1.43; 95% CI 1.12–1.83)
(Table 8). As with allergic rhinitis and allergic dermatitis, we could
not detect any association with maternal smoking during
pregnancy with food allergies (RR = 1.01; 95% CI 0.56–1.82)
(Table 8).
Publication Bias
The funnel plot (Figure 11), although not a valuable way to
assess publication bias in this case due to the small sample size, did
not provide evidence of asymmetry (p = 0.09).
Meta-regression
The meta-regression with the pooled log relative risk as a
dependent variable and the population variable as a moderator,
introduced in the model as a dichotomous variable (adults/
pediatric population), yielded the following results for the children
and adolescents when compared to the adults: allergic rhinitis and
active smoking: RR = 1.55, 95% CI 1.30–1.84; allergic rhinitis and
passive smoking: RR = 0.93, 95% CI 0.81–1.06; allergic dermatitis
and active smoking: RR = 1.18, 95% CI 1.01–1.39; and allergic
dermatitis and passive smoking: RR = 0.83, 95% CI 0.65–1.06.
These results suggest that the associations between allergic rhinitis
and allergic dermatitis with active smoking are significantly greater
among children and adolescents than among adults. Although
these meta-regression RRs were not statistically significant at a
95% level for passive smoking, in Tables 3 and 6 we present the
results of children and adolescent populations as a subgroup both
for active and passive smoking.
Sub-group Analyses in Children and Adolescents
We calculated the random effects pooled relative risks for
children cohort studies, then for children cohort studies and case-
control studies combined. For cohort studies, passive smoking was
not significantly associated with allergic rhinitis (RR = 1.14; 95% CI
0.96–1.34, nine studies), or allergic dermatitis (RR = 1.09; 95% CI
0.96–1.23, 14 studies), but was significantly associated with an
increased risk of food allergy (RR = 1.43; 95% CI 1.11–0.83, five
studies). For cohort and case-control studies combined, passive
smoking was significantly associated with an increased risk for
allergic rhinitis: RR = 1.17 (95% CI 1.00–1.38, ten studies), but not
for allergic dermatitis: RR = 1.07 (95% CI 0.96–1.19, 18 studies).
Sensitivity Analysis
To further evaluate the possibility that the results obtained for
children/adolescents were due to publication bias, we assumed
that cross-sectional studies are the kind of studies that are most
probably rejected by journals in case of null results and
recalculated our pooled estimates under the following extreme
assumptions: (1) published cross-sectional studies are only half of
Figure 11. Funnel plot of relative risk versus standard error of relative risk: food allergy, passive smoking.
doi:10.1371/journal.pmed.1001611.g011
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the studies of smoking and allergic rhinitis ever conducted among
children, (2) all unpublished studies found an RR of 1, (3) the
unpublished studies found the same prevalence of allergic diseases
as the average of the published studies. Under these extreme
assumptions, the random effects pooled estimates for active
smoking still show a significant increase in risk: RR = 1.16 (95%
CI 1.08–1.25) for allergic rhinitis and RR = 1.13 (95% CI 1.05–
1.21) for allergic dermatitis.
Discussion
The results of our systematic review and meta-analysis suggest
that active and passive smoking are associated with a modest
increase in risk for some allergic diseases. In the overall population,
active smoking was associated with a modest increase in the risk for
allergic dermatitis but not allergic rhinitis, while passive smoking
was associated with modest increases in the risks for both allergic
dermatitis and allergic rhinitis. Among children and adolescents, we
observed significant associations between both active and passive
smoking and allergic rhinitis and allergic dermatitis, and passive
smoking was associated with an increased risk for food allergy
In children and adolescents, while the observed increase in risk
for allergic diseases associated with smoking was small, the findings
are important given that to the prevalence of active and passive
smoking in this population can be high. Worldwide, 14% of
adolescents aged 13 to 15 are active smokers with some countries
reaching a prevalence of 40%, and nearly 25% of the children who
smoke have smoked their first cigarette before the age of 10 years
[210]. Furthermore, in the US, more than one-third of children
live with at least one adult smoker [211]. In other parts of the
world, passive exposure to tobacco among children is even higher
as nearly half of children were exposed to tobacco smoke at home
[212]. On the basis of the figures above, in countries with high
smoking prevalence we estimate that 14% of allergic rhinitis and
13% of allergic dermatitis are attributable to active smoking [213].
Eliminating active smoking in children and adolescents would then
prevent one in every seven cases of allergic rhinitis and one in
every eight cases of allergic dermatitis.
That age is an important effect modifier for the relation between
tobacco exposure and risk of allergic diseases is biologically
plausible. The US Surgeon General has suggested that the
immaturity of the respiratory, nervous, and immune systems in
children may make them vulnerable to health effects of smoking
[214]. Furthermore, unlike adults, children have limited options
for avoiding exposure to secondhand smoke and are unable to
reduce the quantity of products inhaled [214].
Table 6. Pooled relative risks and 95% confidence intervals of allergic dermatitis and smoking.
Study Type Number of Studies
RR (95% CI) Fixed
Effects
RR (95% CI) Random
Effects Ria (95% CI) Q test (p-Value)
Active smoking
All studies 33 1.05 (1.04–1.06) 1.21 (1.14–1.29) 0.96 (0.91–1.00) 0.00001
Cohort studies 2 1.23 (1.10–1.38) 1.23 (1.09–1.38) 0.10 (0.00–1.00) 0.3003
Case-control studies 4 1.30 (1.03–1.64) 1.47 (0.92–2.32) 0.73 (0.27–1.00) 0.0160
Cross-sectional studies 27 1.05 (1.04–1.06) 1.21 (1.13–1.30) 0.97 (0.92–1.00) 0.00001
Cohort+case-control studies 6 1.24 (1.13–1.38) 1.27 (1.04–1.56) 0.67 (0.11–1.00) 0.0412
Full adjustment 17 1.05 (1.04–1.06) 1.21 (1.12–1.31) 0.98 (0.93–1.00) 0.00001
Incomplete adjustment 16 1.21 (1.14–1.29) 1.25 (1.09–1.45) 0.77 (0.56–0.98) 0.00001
Adults only 23 1.04 (1.03–1.05) 1.14 (1.07–1.22) 0.96 (0.89–1.00) 0.00001
Children/adolescents only 7 1.36 (1.27–1.46) 1.36 (1.17–1.46) 0.76 (0.44–1.00) 0.0008
Quality score $3 17 1.18 (1.13–1.23) 1.22 (1.11–1.34) 0.78 (0.55–1.00) 0.00001
Quality score ,3 16 1.04 (1.03–1.05) 1.22 (1.11–1.34) 0.98 (0.94–1.00) 0.00001
Passive Smoking
All studies 58 1.04 (1.03–1.06) 1.07 (1.03–1.12) 0.84 (0.71–0.98) 0.00001
Cohort studies 14 0.92 (0.90–0.95) 1.09 (0.96–1.23) 0.89 (0.72–1.00) 0.00001
Case-control studies 5 1.11 (0.94–1.31) 1.10 (0.88–1.38) 0.34 (0.00–1.00) 0.2411
Cross-sectional studies 39 1.08 (1.06–1.09) 1.07 (1.02–1.12) 0.81 (0.63–0.99) 0.00001
Cohort+case-control studies 19 0.93 (0.90–0.95) 1.09 (0.98–1.21) 0.86 (0.66–1.00) 0.00001
Full adjustment 32 1.08 (1.07–1.10) 1.08 (1.03–1.13) 0.81 (0.60–1.00) 0.00001
Incomplete adjustment 26 0.96 (0.94–0.98) 1.06 (0.98–1.14) 0.84 (0.65–1.00) 0.00001
Adults only 4 1.24 (1.03–1.50) 1.26 (1.02–1.55) 0.17 (0.00–1.00) 0.31
Children/adolescents only 53 1.04 (1.03–1.05) 1.06 (1.01–1.11) 0.85 (0.72–0.98) 0.00001
Children ISAAC method 22 1.07 (1.06–1.09) 1.09 (1.04–1.14) 0.73 (0.41–1.00) 0.00001
Children non-ISAAC method 29 0.99 (0.97–1.01) 1.05 (0.97–1.15) 0.89 (0.77–1.00) 0.00001
Maternal pregnancy smoking 19 0.99 (0.95–1.03) 1.07 (0.96–1.19) 0.80 (0.62–0.98) 0.00001
Quality score $3 28 1.04 (1.02–1.05) 1.11 (1.05–1.18) 0.88 (0.74–1.00) 0.00001
Quality score ,3 30 1.06 (1.03–1.09) 1.03 (0.96–1.11) 0.80 (0.63–0.98) 0.00001
aProportion of total variance due to between-study variance.
doi:10.1371/journal.pmed.1001611.t006
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Our finding that maternal exposure is not associated with the
risk of allergic diseases in the offspring confirms the results from a
previous meta-analysis that focused on the risk of allergic
sensitization measured through skin prick positivity or IgE
concentrations [30]. It is possible that the lack of observed
association is due to the existence of bias given that parents of
children at high risk of allergy may selectively avoid smoking
during pregnancy.
The findings from our meta-analysis are subject to several
limitations. The majority of studies were cross-sectional, a design
that does not allow for causal inference and can overestimate
relative risks given its reliance on prevalence ratios. When
restricted to cohort studies our analyses showed that many of
the results were no longer significant, especially for the subgroup
analysis in children and adolescents. There is then some evidence
that the findings may be impacted by study design.
Residual confounding (confounding remaining after adjustment)
may explain some of our findings. For some of our analyses, we
were unable to detect meaningful differences in the results between
studies that had incomplete adjustment for confounders and those
with more complete adjustment for confounders and our findings
were broadly similar when restricting the analyses to studies with
higher quality scores. However, there are likely to be other factors,
such as genetic factors that were not controlled for and may play a
role in the relationship between smoking and allergic diseases.
Although publication bias cannot be ruled out, its magnitude is
likely to be low as shown by the robustness of our sensitivity
analysis.
Several studies assessed allergic diseases through self-report
only, which can lead to misclassification of allergic and non-
allergic conditions. Similarly, the findings are limited by measure-
ment error in the smoking exposure given that a majority of
studies assessed exposure to smoking in a qualitative fashion and
often on a yes/no basis instead of using a quantitative assessment.
Misclassification and measurement error in SHS assessment may
result from a respondent’s lack of knowledge about current or past
exposure, biased recall, whether intentional or unintentional, and
the difficulty in characterizing an exposure in complex indoor
environments [215]. A standard set of items to identify passive
smoking in distinct settings is needed [216]. If misclassification
exists, it is probable that the outcome misclassification is not
differential in regard to smoking and, similarly, measurement error
in smoking assessment is not differential in regard to diagnosis. In
this case, the results would be biased towards the null value, which
means that the association with smoking observed in our meta-
analysis is underestimated.
In our subgroup analyses, we were unable to identify any factors
that accounted for study heterogeneity. Given the high heteroge-
neity estimates, we focused our interpretation on the random
effects estimates. The random effects model gives increased
weights to the effect of small studies, which may introduce bias
in the estimation. It is worth noting that for some of the analyses,
the fixed effects and random effects estimates differ substantially;
this may be due to differences in case or exposure definition and in
adjustment for potential confounders. AU: ok to delete.it appears
that you have said this in the previous sentence.
Our subgroup analyses found stronger evidence for associations
between smoking and allergic diseases in children and adolescents
than adults. Furthermore, our meta-regression suggested that the
association between active smoking and allergic disorders is larger
in children and adolescents than in adults, which advocates for a
transient effect through life. This finding is in accordance with the
‘‘atopic march’’ concept that suggests that the sequence of
sensitization that starts in childhood may show a tendency to
spontaneous remission later in life [217]. It is then plausible that
sensitization to tobacco is mitigated by increasing age. Further
research is needed to verify whether the association between
smoking and risk of allergy in adults is similar for those who started
smoking as an adult and those who started smoking during
childhood or adolescents.
Future studies should minimize measurement error in the
exposure and misclassification bias in the outcome. These studies
should avoid cross-sectional designs, use extensive validated
questionnaires in order to assess smoking in a quantitative
fashion, and should be based on an optimal diagnosis of allergic
diseases.
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Editors’ Summary
Background. The immune system protects the human
body from viruses, bacteria, and other pathogens. Whenever
a pathogen enters the body, immune system cells called T
lymphocytes recognize specific molecules on its surface and
release chemical messengers that recruit and activate other
types of immune cells, which then attack the pathogen.
Sometimes, however, the immune system responds to
harmless materials (for example, pollen; scientists call these
materials allergens) and triggers an allergic disease such as
allergic rhinitis (inflammation of the inside of the nose; hay
fever is a type of allergic rhinitis), allergic dermatitis (also
known as eczema, a disease characterized by dry, itchy
patches on the skin), and food allergy. Recent studies
suggest that all these allergic (atopic) diseases are part of a
continuous state called the ‘‘atopic march’’ in which
individuals develop allergic diseases in a specific sequence
that starts with allergic dermatitis during infancy, and
progresses to food allergy, allergic rhinitis, and finally asthma
(inflammation of the airways).
Why Was This Study Done? Allergic diseases are
extremely common, particularly in children. Allergic rhinitis
alone affects 10%–30% of the world’s population and up to
40% of children in some countries. Moreover, allergic
diseases are becoming increasingly common. Allergic
diseases affect the quality of life of patients and are
financially costly to both patients and health systems. It is
important, therefore, to identify the factors that cause or
potentiate their development. One potential risk factor for
allergic diseases is active or passive exposure to tobacco
smoke. In some countries up to 80% of children are exposed
to second-hand smoke so, from a public health point of view,
it would be useful to know whether exposure to tobacco
smoke is associated with the development of allergic
diseases. Here, the researchers undertake a systematic review
(a study that uses predefined criteria to identify all the
research on a given topic) and a meta-analysis (a statistical
approach for combining the results of several studies) to
investigate this issue.
What Did the Researchers Do and Find? The researchers
identified 196 observational studies (investigations that
observe outcomes in populations without trying to affect
these outcomes in any way) that examined the association
between smoke exposure and allergic rhinitis, allergic
dermatitis, or food allergy. When all studies were analyzed
together, allergic rhinitis was not associated with active
smoking but was slightly associated with exposure to
second-hand smoke. Specifically, compared to people not
exposed to second-hand smoke, the pooled relative risk (RR)
of allergic rhinitis among people exposed to second-hand
smoke was 1.10 (an RR of greater than 1 indicates an
increased risk of disease development in an exposed
population compared to an unexposed population). Allergic
dermatitis was associated with both active smoking
(RR = 1.21) and exposure to second-hand smoke (RR = 1.07).
In the populations of children and adolescents included in
the studies, allergic rhinitis was associated with both active
smoking and exposure to second-hand smoke (RRs of 1.40
and 1.09, respectively), as was allergic dermatitis (RRs of 1.36
and 1.06, respectively). Finally food allergy was associated
with exposure to second-hand smoke (RR = 1.43) when
cohort studies (a specific type of observational study) only
were examined but not when all the studies were combined.
What Do These Findings Mean? These findings provide
limited evidence for a weak association between smoke
exposure and allergic disease in adults but suggest that both
active and passive smoking are associated with a modestly
increased risk of allergic diseases in children and adolescents.
The accuracy of these findings may be affected by the use of
questionnaires to assess smoke exposure and allergic disease
development in most of the studies in the meta-analysis and
by the possibility that individuals exposed to smoke may
have shared other characteristics that were actually respon-
sible for their increased risk of allergic diseases. To shed more
light on the role of smoking in allergic diseases, additional
studies are needed that accurately measure exposure and
outcomes. However, the present findings suggest that, in
countries where many people smoke, 14% and 13% of
allergic rhinitis and allergic dermatitis, respectively, among
children may be attributable to active smoking. Thus, the
elimination of active smoking among children and adoles-
cents could prevent one in seven cases of allergic rhinitis and
one in eight cases of allergic dermatitis in such countries.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001611.
N The UK National Health Service Choices website provides
information about allergic rhinitis, hay fever (including
personal stories), allergic dermatitis (including personal
stories), and food allergy (including personal stories)
N The US National Institute of Allergy and Infectious Disease
provides information about allergic diseases
N The UK not-for-profit organization Allergy UK provides
information about all aspects of allergic diseases and a
description of the atopic march
N MedlinePlus encyclopedia has pages on allergic rhinitis
and allergic dermatitis (in English and Spanish)
N MedlinePlus provides links to further resources about
allergies, eczema, and food allergy (in English and Spanish)
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